Citigroup Inc. Has $172.93 Million Holdings in Astera Labs, Inc. $ALAB

Citigroup Inc. grew its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 31.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 883,194 shares of the company’s stock after acquiring an additional 213,453 shares during the period. Citigroup Inc. owned 0.52% of Astera Labs worth $172,929,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Astera Labs by 21.6% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after purchasing an additional 2,624 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in Astera Labs by 94.6% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock worth $9,908,000 after buying an additional 53,276 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Astera Labs by 34.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock worth $47,208,000 after buying an additional 133,961 shares during the period. Corient Private Wealth LLC acquired a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $543,000. Finally, Paragon Advisors LLC bought a new position in Astera Labs during the 3rd quarter worth approximately $1,829,000. 60.47% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on ALAB shares. JPMorgan Chase & Co. lifted their price target on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Stifel Nicolaus lifted their target price on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Citigroup dropped their price target on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, February 11th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Fourteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $192.89.

Insiders Place Their Bets

In other news, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares in the company, valued at $261,650,077.64. This trade represents a 8.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Philip Mazzara sold 4,849 shares of the stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.80, for a total value of $600,306.20. Following the transaction, the general counsel directly owned 138,084 shares of the company’s stock, valued at $17,094,799.20. This trade represents a 3.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 389,792 shares of company stock valued at $56,013,809 in the last quarter. Company insiders own 12.50% of the company’s stock.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Zacks highlights rising AI connectivity demand and Astera’s expansion of NVLink and Scorpio product lines, framing a multiyear market opportunity that could support revenue growth. ALAB Rides on Strong Connectivity Demand
• Positive Sentiment: Seeking Alpha notes strong fundamentals: revenue more than doubled YoY, very healthy free cash flow margins (>30%), roughly $1.19B cash and no debt — giving Astera flexibility to invest or absorb near‑term headwinds. The Great Astera Labs Reset
• Positive Sentiment: Recent quarterly results beat expectations (EPS and revenue) and management set Q1 2026 guidance; continued demand for high‑speed interconnects supports the growth narrative. Earnings & Guidance
• Neutral Sentiment: Reported short-interest data is effectively immaterial/odd (reported as zero), so short‑pressure does not explain intraday moves — it’s a non‑factor for current trading dynamics. Short Interest Report
• Negative Sentiment: CEO sale: Jitendra Mohan sold 94,971 shares at ~$123.81 (~$11.8M), trimming his stake by ~6.14% — a sizeable single‑day sale that can be viewed negatively by investors. CEO Form 4
• Negative Sentiment: COO sale: Sanjay Gajendra sold 94,971 shares at ~$123.81 (~$11.8M), reducing his holding by ~5.84% — another large insider disposition on the same date that amplifies concern. COO Form 4
• Negative Sentiment: CFO sale: Michael Truett Tate sold 12,001 shares at ~$123.81 (~$1.49M), lowering his stake by ~5.88% — adds to the cluster of senior‑level selling. CFO Form 4
• Negative Sentiment: General Counsel sale: Philip Mazzara sold 4,849 shares at ~$123.80 (~$600k), a smaller but concurrent insider reduction — multiple senior officers selling the same day increases perceived signal of liquidity taking or diversification. GC Form 4

Astera Labs Price Performance

ALAB stock opened at $129.68 on Friday. The stock has a market capitalization of $21.90 billion, a P/E ratio of 106.30, a P/E/G ratio of 2.55 and a beta of 1.50. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The business has a 50-day moving average of $160.40 and a 200-day moving average of $174.33.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The business’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.